targeting braf v600e in metastatic colorectal cancer: where are we today?
Published 1 year ago • 252 plays • Length 5:19Download video MP4
Download video MP3
Similar videos
-
10:08
impact of braf-v600e mutation on the tumour microenvironment and associated genomic alterations ...
-
6:27
targeting braf and mek in colorectal cancer
-
1:17
treatment approaches for braf v600e mutant metastatic colorectal cancer
-
4:19
targeting braf in metastatic crc
-
1:18
how braf v600e-mutated crc is treated differently than other cancers
-
22:10
novel agents and targets in colorectal cancer
-
4:54
case 1: braf-mutated metastatic colorectal cancer
-
6:06
colorectal cancer debate: first line braf v600e - targeted triplet
-
1:12
targeted therapies in metastatic colorectal cancer
-
52:55
optimizing testing and treatment of patients with brafv600e-mutant mcrc in community practice
-
1:11
dr. kopetz on the rationale for the beacon crc study in braf v600e-mutant mcrc
-
2:28
the evolving treatment paradigm for braf v600e-mutant mcrc
-
2:21
editorial - braf mutation in colorectal cancer: an enigmatic target
-
2:33
braf mutations in colorectal cancer
-
1:26
novel treatment strategies for braf v600e-mutant nsclc
-
7:42
egfr-targeted therapy in metastatic colorectal cancer
-
20:52
what is the optimal therapy for braf mutant metastatic colorectal cancer?
-
5:52
primary tumour location in metastatic colorectal cancer impacts overall survival
-
0:58
targeting wnt in braf-mutant colorectal cancer